3-hydroxyflavone has been researched along with Experimental Hepatoma in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Maurya, BK; Trigun, SK | 1 |
Price, KR; Rhodes, MJ; Uda, Y; Williamson, G | 1 |
Fujii, M; Fukuda, M; Hou, DX; Johnson, JA; Miyamori, K; Ushikai, M | 1 |
3 other study(ies) available for 3-hydroxyflavone and Experimental Hepatoma
Article | Year |
---|---|
Fisetin Modulates Antioxidant Enzymes and Inflammatory Factors to Inhibit Aflatoxin-B1 Induced Hepatocellular Carcinoma in Rats.
Topics: Aflatoxin B1; Animals; Antioxidants; Carcinoma, Hepatocellular; Flavonoids; Flavonols; Interleukin-1alpha; Liver Neoplasms, Experimental; Male; Neoplasm Proteins; Oxidative Stress; Oxidoreductases; Rats; Tumor Necrosis Factor-alpha | 2016 |
Induction of the anticarcinogenic marker enzyme, quinone reductase, in murine hepatoma cells in vitro by flavonoids.
Topics: Animals; Catechin; Chamomile; Enzyme Induction; Enzyme Inhibitors; Flavonoids; Flavonols; Kaempferols; Liver Neoplasms, Experimental; Mice; NAD(P)H Dehydrogenase (Quinone); Oils, Volatile; Plants, Medicinal; Quercetin; Tumor Cells, Cultured | 1997 |
Fisetin induces transcription of NADPH:quinone oxidoreductase gene through an antioxidant responsive element-involved activation.
Topics: Animals; Dose-Response Relationship, Drug; Enzyme Induction; Flavonoids; Flavonols; Gene Expression Regulation, Enzymologic; Humans; Liver Neoplasms, Experimental; NAD(P)H Dehydrogenase (Quinone); RNA, Messenger; Time Factors; Tumor Cells, Cultured | 2001 |